AbbVie, several other pharma companies near MFN deal with Trump, sources say

Core Insights - AbbVie and several other drugmakers are expected to announce agreements with the U.S. government to lower certain prescription drug prices and meet demands made by President Donald Trump [1] Group 1: Drug Pricing Agreements - The agreements are aimed at reducing the costs of specific prescription drugs [1] - These negotiations are part of broader efforts by the U.S. government to control drug prices [1] - The announcement is anticipated to take place on Friday, indicating a timely response from the pharmaceutical industry [1]